Cartela AB
Records under this name other than patents Cartela AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Cartela AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,452,677 | Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1 Formerly held Term ended Term ended Apr 14, 2024 · High confidence | Term ended | Term ended Apr 14, 2024 | High confidence |
| US 7,749,710 | Marker for stem cells and its use Formerly held Term ended Term ended Aug 6, 2023 · USPTO record | Term ended | Term ended Aug 6, 2023 | USPTO record |
| US 7,485,429 | Integrin heterodimer and an alpha subunit thereof Formerly held Term ended Term ended Jun 27, 2020 · USPTO record | Term ended | Term ended Jun 27, 2020 | USPTO record |
| US 7,029,858 | Integrin heterodimer and a subunit thereof Formerly held Term ended Term ended Mar 31, 2019 · USPTO record | Term ended | Term ended Mar 31, 2019 | USPTO record |